• 1. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182

Comprehensive Overview of 8-amino-2-Azaspiro[4.5]decan-3-one (CAS No. 880271-29-4): Properties, Applications, and Research Insights

8-amino-2-Azaspiro[4.5]decan-3-one (CAS No. 880271-29-4) is a structurally unique spirocyclic compound that has garnered significant attention in pharmaceutical and chemical research. Its aza-spiro core and functional amino group make it a versatile intermediate for drug discovery, particularly in the development of central nervous system (CNS) therapeutics and enzyme inhibitors. This article delves into its molecular characteristics, synthetic pathways, and emerging applications, while addressing trending topics like AI-driven drug design and sustainable chemistry.

The spirocyclic scaffold of 8-amino-2-Azaspiro[4.5]decan-3-one offers exceptional three-dimensional rigidity, a feature highly sought after in medicinal chemistry to enhance binding affinity and metabolic stability. Researchers frequently explore its potential in neurodegenerative disease targets, such as Parkinson's and Alzheimer's, where spirostructures are known to modulate dopamine receptors and amyloid-beta aggregation. Recent high-throughput screening studies highlight its role in optimizing kinase inhibitors, aligning with the growing demand for precision medicine solutions.

Synthetically, CAS No. 880271-29-4 is accessible via multicomponent reactions or ring-closing metathesis, with green chemistry adaptations gaining traction. Innovations like catalytic asymmetric synthesis and flow chemistry have improved yields and reduced waste, resonating with the industry's shift toward ESG compliance. Analytical techniques such as NMR spectroscopy and X-ray crystallography confirm its stereochemistry, a critical factor for chiral drug development.

Beyond pharmaceuticals, this compound intersects with agrochemical research, where its heterocyclic motifs contribute to novel pest control agents. Its low toxicity profile and biodegradability align with global trends favoring eco-friendly crop protection. Additionally, computational tools like molecular docking and QSAR modeling leverage its structure to predict bioactivity, a hot topic in AI-augmented drug discovery forums.

In summary, 8-amino-2-Azaspiro[4.5]decan-3-one exemplifies the convergence of structural innovation and multidisciplinary applications. Its relevance to CNS disorders, sustainable synthesis, and computational chemistry positions it as a pivotal subject for researchers navigating the future of bioactive small molecules.

• 88842-36-8(3a,6-Methano-3aH-indol-2(3H)-one, hexahydro-8,8-dimethyl-)
• 308364-50-3(4,7-Methano-2H-indol-2-one,octahydro-7,8,8-trimethyl-, (3aS,4R,7R,7aS)-)
• 1217862-78-6(8-Methyl-2-azaspiro[4.5]decan-3-one)
• 1824126-86-4(8-Amino-2-methyl-2-azaspiro[4.5]decan-3-one)
• 196618-65-2(Spiro[bicyclo[3.3.1]nonane-9,3'-pyrrolidin]-5'-one)
• 1862727-19-2(CID 130596291)
• 2137581-56-5(1-Azaspiro[4.5]decan-2-one, 4-ethyl-4-methyl-)
• 64744-50-9(2-Azaspiro[4.5]decan-3-one)
• 784145-12-6(2-Azaspiro[4.5]decan-3-one, 8-(1,1-dimethylethyl)-)
• 196608-67-0(2-Azaspiro[4.5]decan-3-one, 7-methyl-, (5R,7R)-)